Video Experimental Relacionado
Updated: Sep 10, 2025
08:28
Methods for ECG Evaluation of Indicators of Cardiac Risk, and Susceptibility to Aconitine-induced Arrhythmias in Rats Following Status Epilepticus
Published on: April 5, 2011
17.9K
Características clínicas y factores de riesgo para la gravedad y el pronóstico del estado epiléptico convulsivo
Zhen Tian1, Yingchun Xu1, Rundong He1
1Tianjin Huanhu Hospital, Tianjin, China.
Brain and behavior
|August 22, 2025
Resumen
La gravedad del estado convulsivo epiléptico (CSE) está relacionada con la duración de las convulsiones. La puntuación modificada de gravedad del estado epiléptico (mSTESS) predice los resultados del paciente, guiando la atención de emergencia neurológica crítica.
Área de la Ciencia:
- Neurología
- Medicina de emergencia
- Neurociencia clínica
Sus antecedentes:
- El estado convulsivo epiléptico (CSE) es una emergencia neurológica crítica que requiere una evaluación inmediata.
- La comprensión de los factores de riesgo de la gravedad y el pronóstico de la EEC es vital para las estrategias de tratamiento eficaces.
- Los conocimientos actuales sobre los factores de riesgo de ECE siguen siendo incompletos y requieren una mayor investigación clínica.
Objetivo del estudio:
- Analizar las características clínicas de los pacientes con EEC.
- Identificar los factores de riesgo que influyen en la gravedad de la ECE.
- Determinar los factores predictivos del pronóstico de la EEC.
Principales métodos:
- Análisis retrospectivo de 104 pacientes con ECE ingresados entre julio de 2023 y diciembre de 2024.
- Los pacientes fueron clasificados por la puntuación modificada de gravedad del estado epiléptico (mSTESS) para la gravedad y por la escala de resultados de Glasgow (GOS) para el pronóstico.
- Se recopilaron y analizaron datos clínicos que incluían la edad, la etiología, la duración de las convulsiones y las comorbilidades.
Principales resultados:
- El accidente cerebrovascular fue la etiología más común (43,3%); el 62,5% de los pacientes presentaron EEC grave (mSTESS ≥ 4).
- La duración de las convulsiones tuvo un impacto significativo en la gravedad de la EEC (p < 0,05).
- La puntuación mSTESS fue un predictor significativo de mal pronóstico (GOS ≤ 3) (p < 0,05).
Conclusiones:
- La duración de las convulsiones es un factor de riesgo independiente para la gravedad de la EEC.
- La puntuación mSTESS predice efectivamente el pronóstico en pacientes con EEC.
- Estos hallazgos ayudan en la gestión de emergencias neurológicas y mejoran los resultados de los pacientes.
Palabras clave:
Características clínicasestado convulsivo epilepticusel pronósticoFactores de riesgola gravedadMás Videos Relacionados
Videos de Conceptos Relacionados
01:13Seizures: Classification
586
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
586
01:24Epilepsy and Seizures: Overview
277
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
277
01:30Electroconvulsive Therapy
185
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
185
01:21Aneurysm II: Clinical Manifestations and Diagnostic Studies
22
Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
22
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
446
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
446
01:20Antiepileptic Drugs: Potassium Channel Activators
274
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
274